Julie DeLong is a Managing Director in the Transaction Advisory Services practice of Navigant Consulting, Inc. Julie is responsible for valuation analysis and financial advisory services for clients seeking assistance with transaction support, financial reporting, strategic decision making, tax compliance, regulatory compliance, and litigation support.
Julie has over 25 years of experience providing valuation consulting services to clients in a wide variety of industries, including life sciences, health care, computer software, financial services, manufacturing, consumer products, retail, and education. She specializes in the valuation of business interests, intangible assets, and fee-for-service arrangements.
Julie is a senior leader in the Life Sciences Valuation Practice at Navigant, advising biotechnology, pharmaceutical, and medical device companies on the valuation issues they face. Julie routinely assist clients with the valuations for regulatory compliance. This experience includes valuations of fee-for-service arrangements, including bona fide service fees, for services provided by her client’s customers, such as specialty pharmacies, specialty distributors, wholesalers, group purchasing organizations, etc. Julie’s expertise includes assisting clients with developing and documenting fair market value hourly rates and other payments to healthcare professionals for consulting on product development, serving on advisory boards, and conducting speaker programs, as well as providing other consulting services.
Julie has performed hundreds of valuations to be used for financial and tax reporting purposes. These include valuations for reporting under Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 805, 350, 360, 718, and 820. Examples of intangible assets valued for purchase accounting under FASB ASC 805 are: management agreements, customer relationships and contracts, trade names, noncompete agreements, patented and other proprietary technology, in-process research and development, and computer software. In addition, Julie has valued contingent purchase consideration and other liabilities for financial and tax reporting. Julie’s financial and tax reporting experience also includes the valuation of stock options and other employee compensation for FASB ASC 718.